Home › Company › Publications › Presentations

PresentationsPresentations

The following are presentations (posters) C-TASC staff have created or contributed to:

Bauserman, Robert

  1. Ballas, SK, Bauserman, RL, McCarthy, WF, Waclawiw, MA, & Barton, BA (December, 2009). Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia. 2009 Annual Meeting of the American Society of Hematology in New Orleans, LA, December (poster).
  2. Ballas, SK, McCarthy, WF, Bauserman, RL, Castro, OL, Swerdlow, PS, Waclawiw, MA, & Barton, BA (December, 2009). Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH). 2009 Annual Meeting of the American Society of Hematology in New Orleans, LA, December (poster).
  3. Ballas, SK, McCarthy, WF, Bauserman,  RL, Castro,  OL, Waclawiw , MA, & Barton, BA (December, 2009). Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia. 2009 Annual Meeting of the American Society of Hematology in New Orleans, LA, December (poster).
  4. Ballas, SK, McCarthy, WF, Guo, N, Brugnara, C, Kling, G, Bauserman, RL, & Waclawiw, MA (December, 2009). Footprints of Response to Hydroxyurea Are in the Hemogram. 2009 Annual Meeting of the American Society of Hematology in New Orleans, LA, December (abstract will be published online-only on the ASH abstracts site at http://bloodjournal.hematologylibrary.org/misc/ASH_Meeting_Abstracts_Info.dtl in December 2009).
  5. Ballas, SK, McCarthy, WF, Bauserman,  RL, Valafar, F, Waclawiw, MA, Barton, BA, & Kutlar, A (December, 2009). Definition of the responder to HU therapy: Revisited. 2009 Annual Meeting of the American Society of Hematology in New Orleans, LA, December (poster).
  6. Bauserman, RL, McCarthy, WF, Barton, BA, Waclawiw, MA, & Ballas, SK (October, 2009).  The association between hydroxyurea treatment and employment patterns in sickle cell patients.  37th annual convention of the Sickle Cell Disease Association of America, Orlando, FL (oral presentation).
  7. McCarthy, WF, Ballas, SK, Guo, N, Bauserman, RL, Waclawiw, MA, Barton, BA, and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (August, 2009).  Exposure to hydroxyurea and pregnancy outcomes.  25th anniversary International Conference for Pharmacoepidemiology and Therapeutic Risk Management, Providence, RI (poster).
  8. Bauserman, RL, McCarthy, WF, Barton, BA, Ballas, SK, and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (May, 2009).  Opioid utilization among adult patients with sickle cell anemia.  American Society of Addiction Medicine annual conference, New Orleans, LA (poster).
  9. Smith, WR, Bauserman, RL, McCarthy, WF, Barton, BA, & Ballas, SK (February, 2009).  Effect of geography and climate on pain frequency in patients enrolled in the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.  3rd Annual Sickle Cell Disease Research and Education Symposium, Fort Lauderdale, FL (poster).
  10. Smith, Wally R., Bauserman, R., McCarthy, W., & Barton, B. (September, 2007).  Pain frequency in relation to geography and climate in the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.  Presented at 35th Anniversary of the Sickle Cell Disease Program and the Sickle Cell Disease Association of America, Inc., Washington, DC.
  11. Bauserman, R., & Albertson, A. (May, 2007).  Cereal/breakfast consumption, body image, weight attitudes, and dieting in adolescent females.  Presented at 19th Annual Convention, Association for Psychological Science, Washington, DC.
  12. Bauserman, R, Thompson, R, and  (May, 2007).  Before and after: “Critical event” analysis with longitudinal data using SAS.  Presented at 28th Annual Meeting, Society for Clinical Trials, Montreal, Quebec.
  13. Bauserman, R. (August, 2006).  Geography/meteorology and sickle cell pain.  Presented at Annual Sickle Cell Disease Clinical Research Meetings, NHLBI, National Institutes of Health, Bethesda, MD.
  14. Bauserman, R, Shifren, K, & Furnham, A. (July, 2005).  Condom use self-efficacy, personality, and body image in male and female American and British students.  Poster presented at XVII World Congress of Sexology, Montreal, Quebec.
  15. Bauserman, R., Bowlin, C, Shea, MA, & Tomoyasu, N (July, 2005).  Psychosocial predictors of HIV risk in incarcerated, ethnically diverse men and women.  Poster presented at XVII World Congress of Sexology, Montreal, Quebec.
  16. Bauserman, R, Shea, MA, & Tomoyasu, N (June, 2005).  Psychosocial predictors of condom risk: Their utility in diverse populations.  Poster presented at 2005 National HIV Prevention Conference, Atlanta, GA.

Forman, Sandra

  1. Stamler J, Forman S:  Long‑term prognostic significance of blood pressure after recovery from myocardial infarction.  American Heart Association, November 1977.
  2. Forman S, Canner PL:  Coding of electrocardiograms ‑ utiliza­tion of results from quality control programs for end point diagnosis and measurement.  Society for Clinical Trials, May 1981.
  3. Bren B, Wasserman AG, Sheehan FH, Forman S, Dodge HT, Ross AM: Electrocardiographic evolution during acute MI as a correlate of left ventricular function outcome.  American Heart Asso­ciation, November 1985.
  4. Markis JE, Brewer CC, Alderman J, McKay RG, Forman S, Braunwald E:  Myocardial infarction without early coronary angiographic evidence of occlu­sion.  American Heart Association, November 1985.
  5. Forman S:  CCU Logs ‑ Who are the gate keepers?  Society for Clinical Trials, May 1985.
  6. Knatterud GL, Forman SA:  Patient recruitment experience in the Thrombolysis in Myocardial Infarction Trial.  NHLBI Recruit­ment Workshop, April 1986.
  7. Forman S:  The pitfalls of incomplete data set analysis.  Society for Clinical Trials, May 1986.
  8. Terrin M, Forman S:  Compound end points in clinical trials.  Society for Clinical Trials, May 1986.
  9. Williams DO, Forman S:  Coronary angioplasty following rt‑PA in acute MI.  ACC, March 1987.
  10. Rogers W:  Preliminary ventricular function following r-tPA in the NHLBI TIMI-II Pilot Study.  Circulation 1987; 76:IV-260. 
  11. Garrahy PJ, Henzlova MJ, Forman S, Rogers WJ:  Has thrombolytic therapy improved survival from cardiogenic shock?  Thrombolysis in Myocardial Infarction (TIMI-II) results.  AHA, November 1989. 
  12. Mueller HS, Cohen LS, Williams DO, Forman S, Solomon R, Braunwald E, and the TIMI II Investigators:  Subgroup analysis of the TIMI II Study.  ACC, March 1991.
  13. Forman S, Noble P, for the TIMI Investigators.  Management of Study Proposals:  From an Idea to a Manuscript.  Society for Clinical Trials, July 1991.
  14. Terrin M, Ross R, Forman S, Wackers F, Zaret B, Knatterud G.  The Importance of Counting All the Patients.  Society for Clinical Trials, July 1991.
  15. McMahon R, Thompson B, Forman S.  Subgroup Analyses in Clinical Trials.  Society for Clinical Trials, July 1991.
  16. Raiz P, Frederick M, Forman S.  Management of Data Files in Preparation for Statistical Analysis.  Society for Clinical Trials, July 1991.
  17. Cox DA, Rogers WJ, Maske L, Forman S, Solomon R for the TIMI Investigators.  What is the Outcome of Acute MI Patients Who Are Free of Chest Pain at Onset of Lytic Therapy?  J Am Coll Cardiol 1992; 19:154A. 
  18. Tofler G, Muller J, Forman S, Solomon R, Braunwald E, and the TIMI Investigators.  Determinants of the Circadian Pattern and Physical Activity at the Onset of Myocardial Infarction.  J Am Coll Cardiol 1992; 19:178A.
  19. McKendall GO, Forman S, Sopko G, Braunwald E, Williams DO and TIMI Investigators.  The Value of Rescue PTCA Following Unsuccessful Thrombolytic Therapy:  A Report From TIMI.  J Am Coll Cardiol 1993; 21:396A.   
  20. Terrin ML, Williams DO, Kleiman N, Willerson J, Mueller H, Desvigne-Nickens P, Forman SA, Knatterud GL, Braunwald E and TIMI Investigators.  Two-and Three-Year Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Clinical Trial.  J Am Coll Cardiol 1993; 21:176A. 
  21. Raiz P, Forman S.  Creating Archival Tapes for Sharing Final Study Data.  Society for Clinical Trials, May 1993.
  22. Mirenzi E, Forman S.  Centralized Control of an Automated Telephone Response System.  Society for Clinical Trials, May 1993.
  23. Mueller HS, Forman SA, Menegus MA, Cohen LS, Knatterud GL, Braunwald E.  Prognostic Significance of Nonfatal Reinfarction:  Results of TIMI II.  Circulation 1993; 88(Suppl):490. 
  24. Pepine CJ, Andrews T, Forman S, Hill JA, Pratt C, Rogers WJ, Steingart R, Conti CR for the ACIP Study Group.  Relationship of patient characteristics to asymptomatic cardiac ischemia: Patients screened for the Asymptomatic Cardiac Ischemia Pilot (ACIP).  Eur Heart J 1993; 14:137. 
  25. Forman S, Terrin M, Ra K, Bowden G, Giro R.  A Treatment Allocation System which Preserves Randomization Schedules and Intent-to-Treat.  Society for Clinical Trials, May 1994.  Controlled Clinical Trials 1994;15:101S.
  26. Mirenzi ED, Forman S.  Monitoring Study Medications Over Time in a Multicenter Clinical Trial with Three Categories of Medication.  Society for Clinical Trials, May 1994.  Controlled Clinical Trials 1994;15:88S.
  27. Steingart RM, Forman S, Mueller H, Moisa R, Coglianese M, Frishman W, Gambino A, Williams G, Bittner V, Vita G, Handberg E, Horan M, and Conti CR for the ACIP Investigators.  Factors limiting the enrollment of women in randomized coronary artery disease trials.  J Amer Coll Cardiol 1994; 23(Suppl A):6. 
  28. Caracciolo EA, Forman SA, Stone PH, Sopko G, Conti CR, Chaitman BR, for the ACIP Investigators.  Diabetics with coronary disease have less severe ambulatory ischemia and a similar prevalence of asymptomatic ischemia compared with nondiabetic patients:  An ACIP database study.  J Amer Coll Cardiol 1994; 23(Suppl A):318. 
  29. Handberg E, Baker A, Barry J, Duke G, Byers S, Dvorak L, Elstob J, Francis M, Kolb R, MacCallum G, Townsend S, Whittom L, Hemingway K, Forman S, Pepine CJ, Conti CR for the ACIP Investigators.  Sources and characteristics of patients suitable for randomized coronary artery disease trials:  An ACIP data base study.  J Amer Coll Cardiol 1994; 23(Suppl A):246. 
  30. Chaitman BR, Stone P, Knatterud G, Forman S, Sopko G, Bourassa M, Pratt C, Rogers W, Conti CR for the ACIP Investigators.  Exercise Test Results in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study:  Impact of Anti-ischemia Therapy on 12-Week Outcome.  Circulation 1994; 90(Part 2):I-328. 
  31. Rogers WJ, Bourassa M, Andrews A, Bertolet B, Blumenthal R, Chaitman B, Dymond D, Forman S, Geller N, Goldberg D, Habib G, Masters R, Moisa R, Mueller H, Pearce D, Pepine C, Selwyn A, Sopko G, Steingart R, Stone P, Conti CR for the ACIP Investigators.  Asymptomatic Cardiac Ischemia Pilot (ACIP) Study:  1 Year Follow-up.  Circulation 1994; 90(Part 2):I-17. 
  32. Bourassa M, Pepine C, Forman S, Rogers W, Stone P, Chaitman B, Mahmarian J, Sopko G, Conti R for the ACIP Investigators.  Effects of Coronary Angioplasty and Coronary Artery Bypass Graft Surgery on Recurrent Angina and Ischemia in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.  Circulation 1994; 90(Part 2):I-530. 
  33. Hall C, Cannon C, Forman S, Braunwald E for the TIMI II Investigators.  Prognostic Value of N-Terminal Proatrial Natriuretic Factor Plasma Levels Measured within the First 12 Hours after Myocardial Infarction: Circulation 1994; 90(Part 2):I-110.
  34. Ketterer MW, Freedland K, Krantz DS, Kaufmann P, Sheps D, Knatterud G, Raczynski J, Carney R, Lindholm L, Stone P, Light K, Zeffert A, Smith S, Forman S, for the PIMI Investigators.  Correlates of Anginal Pain in Treadmill Positive Patients:  The Psychophysiological Investigators of Myocardial Ischemia (PIMI) Study.  Proceedings of the Academy of Psychosomatic Medicine, 1994;41:14. 
  35. Pepine CJ, Chaitman BR, Pratt C, Bourassa MG, Stone PH, Knatterud GL, Forman S, Sopko G, Conti CR for the ACIP Investigators.  Absence of Ischemia on Ambulatory ECG Monitoring During Treatment as a Predictor of Outcome.  A Report from the ACIP Study.  J Amer Coll Cardiol 1995; 25(Suppl A):312A.
  36. Bourassa MG, Knatterud GL, Pepine CJ, Sopko G, Rogers WJ, Geller NL, Dyrda I, Forman SA, Chaitman BR, Conti CR for the ACIP Investigators.  Asymptomatic Cardiac Ischemia Pilot (ACIP) Study:  Improvement of Cardiac Ischemia at 1 Year Following PTCA and CABG.  Eur Heart J 1995; 16(suppl.):253. 
  37. Ketterer MW, Krantz D, Kaufmann P, Sheps D, Forman S, Raczynski J, Lindholm L, Freedland K, Carney R, Stone P and the PIMI Investigators.  Susceptibility to Acute Mental Stress Induced Ischemia in PIMI.  Psychosomatic Medicine 1995;57:78.
  38. Freedland KE, Carney RM, Forman S, Knatterud GL, Kaufmann PG, Ketterer MW, Krantz DS, Light K, Lindholm L, Raczynski J, Stone P for the PIMI Investigators.  Psychological Correlates of Anginal Symptoms During Positive Exercise Treadmill Tests.  Psychosomatic Medicine 1995; 57:74.
  39. Pepine C, Bertolet B, Robinson M, Lindholm L, Greene A, Goldberg D, Forman S, Cohen J, Sheps D, Kaufmann P, Stone P, Knatterud G, Light K, Ketterer M, McMahon R, Raczynski J.  Relationship of Psychological Characteristics to Daily Life Ischemia:  Patients Enrolled in the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study.  Circulation 1995; 71:931. 
  40. Becker LC, Pepine CJ, Bonsall R, Cohen JD, Goldberg AD, Coghlan C, Forman S, Sheps DS, Kaufmann PG and PIMI Investigators.  Left Ventricular, Peripheral Vascular and Neurohumoral Responses to Mental Stress in Normal Middle Aged Men and Women.  Circulation 1995; 92:I-677.
  41. Forman S, Thompson B, Knatterud G.  Selection of appropriate controls for comparison of survival curves with time-dependent events.  Controlled Clinical Trials 1995; 16:3S:94S.
  42. Pepine CJ, Mark D, Bourassa M, Chaitman B, Knatterud G, Forman S, Pratt C, Sopko G, Conti CR.  Cost implications for treatment of cardiac ischemia: An ancillary Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.  J Am Coll Cardiol 1996; 27(Suppl A):186A. 
  43. Steingart RM, Mahmarian JJ, Forman S, Sharaf BL, Coglianese ME, Miller DD, Goldberg AD, Bloom MF, Byers S, Dvorak L for the ACIP Investigators.  Coronary anatomy, stress myocardial infarction perfusion defects, and ambulatory electrocardiographic ischemia.  What is the relationship?  An ACIP Ancillary Study.  J Am Coll Cardiol 1996; 27(Suppl A):90A. 
  44. Davies RF, Goldberg AD, Pratt C, Deanfield J, Forman S, Knatterud G, Conti CR.  Outcomes of patients with asymptomatic ischemia randomized to initial strategy of revascularization versus medical therapy.  Circulation 1996;94(Suppl 1):I-206. 
  45. Forman S.  Evaluating Treatment Efficacy in Subgroups Determined by Patient Responses: A Classic Example.  Presented at a Plenary Session on Post-randomization comparisons. The impossible, recognition and alternatives in basic analysis.  17th Annual Meeting of the Society for Clinical Trials.  May 1996.
  46. Thompson B, Forman S, Terrin M. The analysis of transformed count data in clinical trials. Cont Clin Trials 1997;18(3S):131S.
  47. McMahon RP, Knatterud GL, Forman SA. Impact of fixed plus stochastic selection at entry on regression to the mean and study power: Application to recurrent events. Cont Clin Trials 1997; 18(3S):168S.
  48. Terrin ML, Forman S, Fick S, Clarke E, Gross R, Gerstenblith G, Gottlieb S, Brinker J, Kasper E.  Facsimile copy (FAX) transmission data entry direct from clinical sites in the CHF Team Study.  Presented at the 20th Annual Meeting of the Society for Clinical Trials, May 1999.  Cont Clin Trials 1999; 20(2S):78S.
  49. Forman S, Handy C, Fuller C, Knatterud GL.  Comparison of data quality using three data entry methods.  Presented at the 3rd Joint Meeting of the International Society for Clinical Biostatistics and Society for Clinical Trials, July 2003.  Cont Clin Trials 2003; 24(3S):186S.
  50. Fick S, Forman S, Handy C, Knatterud GL.  Reduction of workload for clinical centers in preparation for Mortality and Morbidity Classification Committee review.  Presented at the Society for Clinical Trials meeting, May 2004.  Journal of the Society for Clinical Trials 2004;1:235.
  51. Terje Steigen, Vinod Jorapur, Christopher E Buller, Vladimír Džavík, Marecelo Cardona, David Almond, Neil Brass, Jeffrey Burton, Aleksander Zurakowski, Sandra Forman, Gervasio A. Lamas, Judith S. Hochman, GB John Mancini. Association of Myocardial Perfusion Grade after late infarct reperfusion with baseline indices of global LV function; analysis from the Total Occlusion Study of Canada-2. Circulation 2006; 114:17(suppl III) III 2465.
  52. Eric J. Rashba, Judith S. Hochman, Jean-Philippe Couderc, Gervasio A. Lamas, Sharri M. Hollist, Vladimír Džavík, Warren Cantor, Carlos Vozzi, Christopher Buller, Sandra Forman, John R. Ross, Antonio Carlos Carvalho. Electrophysiological Effects of Late PCI of Persistently Occluded Infarct-Related Arteries 3-28 Days After Myocardial Infarction: Results From the EP Ancillary Study of the Occluded Artery Trial (OAT-EP). Presented at ACC LBCT Session - Monday, March 26, 2007.
  53. Camille A. Pearte, James E. Udelson, Mariusz Kruk, Harmony R. Reynolds, Witold Ruzyllo, Zygmunt Sadowski, Anna Teresinska, Bartosz Bychowiec, Thomas Höchtl, Jose Antonio Marin-Neto, Eric A. Cohen, Benita Busz-Papiez, Paulo Caramori, Christopher Adlbrecht, Carey Kimmelstiel, Christopher E. Buller, Sandra Forman, Gervasio A. Lamas, Judith S. Hochman. Infarct Size, Viability, and Correlates in Patients Presenting With a Persistent Total Occlusion of the Infarct-Related Artery 3-28 Days Post Myocardial Infarction: An Occluded Artery Trial (OAT) Substudy. J Am Col Cardiol 2007; 49(9) suppl A, 199.
  54. Christopher E Buller, G. B. John Mancini, Vladimír Džavík, Matthias E Pfisterer, James M Rankin, Ronald G Carere, Lampros K Michalis, Jean Renkin, Sandra A Forman, Pedro F Abreu, Gervasio A Lamas, Judith S Hochman. PCI Failure in the Occluded Artery Trial (OAT): Frequency, Mechanisms, and Outcome. Circulation, Oct 2007; 116: II_416.
  55. Christopher E Buller, Vladimír Džavík, Sandra A Forman, Witold Ruzyllo, Pawel E Buszman, Lampros K Michalis, G. B. John Mancini, Jean Renkin, Matthias E Pfisterer, Boban Thomas, Gervasio A Lamas, Judith S Hochman. Similar Long-Term Outcomes After PCI Success, PCI Failure, and no PCI in the Occluded Artery Trial (OAT). Circulation, Oct 2007; 116: II_525 - II_526.
  56. Christopher E Buller, James M Rankin, Jean Renkin, Ronald G Carere, Vladimír Džavík, Witold Ruzyllo, Sandra A Forman, Pawel E Buszman, G. B. John Mancini, Pedro F Abreu, Gervasio A Lamas, Judith S Hochman. Did Early Hazard of PCI Offset Late Benefit in the Occluded Artery Trial (OAT)? Circulation, Oct 2007; 116: II_667.
  57. Mariusz Kruk, Jacek Kadziela, Zygmunt P Sadowski, Bruce A Barton, Daniel B Mark, Sandra A Forman, Harmony R Reynolds, Aldo P Maggioni, Jonathan Leor, John G Webb, Michael Kapeliovich, Jose Antonio Marin-Neto, Harvey D White, Gervasio A Lamas, Judith S Hochman. Predictors of Outcome and the Lack of Effect of PCI Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction: Results from the Occluded Artery Trial (OAT). Circulation, Oct 2007; 116: II_625.
  58. Irene Lang, Sandra A Forman, Aldo P Maggioni, Witold Ruzyllo, Carlos Vozzi, Jean Renkin, P Gabriel Steg, Jose Maria Hernandez-Gardia, Krzysztof Zmudka, Manuel Jimenez-Navarro, George Sopko, Gervasio A Lamas, Judith S Hochman. Causes of Death in Early MI Survivors With Persistent Vessel Occlusion: Results from the Occluded Artery Trial (OAT). Circulation, Oct 2007; 116: II_625.
  59. James E Udelson, Camille A Pearte, Carey D Kimmelstiel, Mariusz Kruk, Anna Teresinska, Bartosz Bychowiec, Jose Antonio Marin-Neto, Thomas Höchtl, Eric A Cohen, Paulo Caramori, Benita Busz-Papiez, Christopher Adlbrecht, Zygmunt P Sadowski, Witold Ruzyllo, Sandy A Forman, Deborah J Kinan, Gervasio A Lamas, Judith S Hochman. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of Infarct Zone Viability on Left Ventricular Remodeling After PCI vs. Medical Therapy Alone. Circulation, Oct 2007; 116: II_624 - II_625.
  60. Vladimír Džavík, Chris E. Buller, Gerard Devlin, Eric A. Cohen, Luc Bilodeau, John G. Webb, Deborah Atchison, Sandra Forman, Gervasio A. Lamas, Judith S. Hochman. Outcome after percutaneous coronary intervention with drug-eluting stents in patients with persistent infarct artery occlusion after myocardial infarction. European Heart Journal (2007) 28 (Abstract Supplement), 578.
  61. Gerard P. Devlin, Daniel B. Mark, Gervasio A. Lamas, Antonio C. Carvalho, Vladimír Džavík, Sandra A. Forman, Carlos R. Vozzi, Michael Ragosta, Jamie M. Rankin, Paulo Caramori, George Sopko, Eduardo Balcells, Jonathan Leor, Bruce A. Barton, Judith S. Hochman. Routine PCI Improves Short but not Long term Angina Status in Patients with an Occluded Infarct Artery: Results from the Occluded Artery Trial (OAT). J Am Col Cardiol. 51(10) Suppl A, A222.
  62. Ph. Gabriel Steg, Arthur Kerner, Christopher E. Buller, Sandra A. Forman, Harvey D. White, Antonio C. Carvalho, Harmony R. Reynolds, Viliam Fridrich, Eric A. Cohen, G. B. John Mancini, Gervasio A. Lamas, Judith S. Hochman. Collateral Flow to the Occluded Infarct-related Artery is Associated with a Lower Rate of Heart Failure in the Occluded Artery. J Am Col Cardiol. 51(10) Suppl A, A215.
  63. Warren J. Cantor, Gervasio A. Lamas, Eugenia Nikolsky, Camille A. Pearte, Vankelpuran S. Srinivas, Sandra A. Forman, Venu Menon, John R. Ross, Sérgio B. Baptista, Peter Meciar, Zygmunt Sadowski, Judith S. Hochman. Impact of Stress Testing Prior to PCI or Medical Management on Outcomes of Patients With Persistent Total Occlusion After Myocardial Infarction: Analysis From the Occluded Artery Trial (OAT). J Am Col Cardiol. 51(10) Suppl A, A191.
  64. Venu Menon, Camille A. Pearte, Christopher E. Buller, Ph. Gabriel Steg, Sandra A. Forman, Harvey D. White, Paolo N. Marino, Demosthenes G. Katritsis, Paulo Caramori, Ricardo Lasevitch, Krystyna Loboz-Grudzien, Aleksander Zurakowski, Gervasio A. Lamas, Judith S. Hochman. Lack of Benefit with PCI for Total Occlusions in Stable Patients Following Myocardial Infarction is Time Independent: Results from the Occluded Artery Trial (OAT). J Am Col Cardiol. 51(10) Suppl A, A201.
  65. Mariusz Kruk, Christopher E. Buller, Vladimír Džavík, G. B. John Mancini, Peter Kurray, James Enlou Tcheng, Venu Menon, Sandra A. Forman, Gervasio A. Lamas, Judith S. Hochman. Late recanalization of infarct related artery has no impact on clinical outcomes regardless of ejection fraction: Results from the Occluded Artery Trial (OAT). European Heart Journal (2008) 29 (Abstract Supplement), 679.
  66. Lukasz Malek, Harmony R. Reynolds, Carlos Vozzi, Mieczyslaw Dziarmaga, John Kerswell French, G. B. John Mancini, Sandra A. Forman, Jean Renkin, Gervasio A. Lamas, Judith S. Hochman. Late coronary intervention in stable patients after myocardial infarction for totally occluded LADs does not reduce events compared to medical therapy alone. Results from the Occluded Artery Trial (OAT). European Heart Journal (2008) 29 (Abstract Supplement), 514-515.
  67. Harmony R Reynolds, Jacqueline E Tamis-Holland, Shari Similo Kronsberg, Philippe Gabriel Steg, Antonio C Carvalho, Krystyna Loboz-Grudzien, Mariusz Kruk, George Sopko, Witold Ruzyllo, Camille A Pearte, Sandra A Forman, Gervasio A Lamas, and Judith S Hochman. Sex Differences in Outcomes after Myocardial Infarction with Persistent Total Occlusion of the Infarct Artery: Analysis of the Occluded Artery Trial. Circulation, Oct 2008; 118: S_967.
  68. CB Overgaard, CE Buller, AP Maggioni, J Leor, W Ruzyllo, J Burton, G Reis, SA Forman, G Devlin, W Banasiak, G Lamas, JS Hochman, V Džavík. Late Clinical Outcomes Of Diabetic Patients Randomized In The Occluded Artery Trial (OAT). CCS (2008) Abstract #0431.
  69. Venu Menon, Antonio Carvalho, Christophe Thuaire, Sandra A. Forman, Jose Marconi, Krystyna Jaworska, Yoav Turgeman, Gervasio A. Lamas, Judith S. Hochman. Failure Timely Identify the Posterior Circulation Infarct Related Artery: Observations from the Occluded Artery Trial.  ESC(2009) Abstract #85206.
  70. Liu L, Forman S, Barton B.  Fitting Cox Model Using PROC PHREG and Beyond in SAS. SAS Global Forum Proceedings, 2009 May; 236-2009

Frederick, Margaret

  1. Bryant MF: Interval estimation of an ED50 using the Spearman-Karber procedure: An application of the bootstrap.  Presented at the Biometric Society ENAR spring meeting.  1986.
  2. Bryant M, Wahrenberger D and Ruey P.  Application of the SAS7 annotate facility and macro language for customized graphics.  Poster session - SAS Users Group International Conference Proceedings: SUGI 13, Cary, NC:SAS Institute, Inc.
  3. Churella H, Lagocki R, Neider K, and Bryant M.  Plasma transthyretin concentrations in low-birth-weight infarcts after hospital discharge.  Poster session - presented at the American Association for Clinical Chemistry Annual Meeting, 1987.
  4. Chaitman B, Younis L, Shaw L, Winder D, Bryant M, et al.  Exercise ECG test results in the TIMI II Trial.  Presented at the American College of Cardiology meeting, March 1990.
  5. Berger P, Ruocco N, Ryan T, Frederick M, Forman S, Podrd P.  Incidence and significance of primary ventricular tachycardia/fibrillation during myocardial infarction treated with rt-PA: Results from TIMI II.  Presented at American Heart Association meeting, November, 1990.
  6. Berger P, Ruocco N, Ryan T, Diver D, Frederick M, Sharaf B, Feit F, Attubato M, Faxon D.  Incidence and significance of mitral regurgitation following first myocardial infarction treated with rt-PA: Results from TIMI II.  Presented at American College of Cardiology Meeting, March 1991.
  7. Currier JW, Kalan JM, Ruocco NA Jr., Frederick MM, Faxon DP, Roberts WC, Ryan TR and the TIMI Research Group.  Cardiac rupture after myocardial infarction treated with tissue plasminogen activator: Results from TIMI II.  Presented at the American College of Cardiology Meeting, March 1991.
  8. Raiz P, Frederick M, and Forman S.  Management of data files in preparation for statistical analysis.  Presented as a Poster Session at the Society for Clinical Trials meeting, July 1991.
  9. Freedman R, Bielory L, Hill R, Smith E, Thompson B, Jacob R, Wigley F, Geller N, Hunsberger S, Kaufman P, Attanasio V, Mayes M, Middaugh S, Frederick M, Medsger T, Haythornthwaite J, Wise R, Maricq H, Jennings R.  The Raynaud’s Treatment Study: A Comparison of Behavioral and Pharmacologic Interventions.  Presented at the Society of Behavioral Medicine Meeting, April 1997.
  10. Hanson IC, Frederick MM, McIntosh K.  Preliminary Evaluation of Living Uninfected Children for Mitochondrial (MT) Defects: Women and Infants Transmission Study (WITS).  Presented at the 7th Conference on Retroviruses and Opportunistic Infections, February 2000.
  11. Moye J, Frederick M, Chantry C. Handelsman E, Turpin D, Paul M. Ten-year follow-up of somatic growth in children born to women infected by human immunodeficiency virus. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, February 2001. 
  12. Thorpe L, Frederick M, Buscher S, Davenny K, Green K, Landesman S, Miotti P, Pitt J, Zorilla C, Hershow R. The effects of hard drug use on virological and immunological parameters of HIV-infected women presented at the 8th Conference on Retroviruses and Opportunistic Infections, February 2001. 
  13. Paul M, Frederick M, Chantry C, Turpin D, Pitt J, Handelsman E, Cooper E, Hoff R, Smeriligio V, Read J. Morbidity among 940 uninfected children born to HIV-1 infected women as measured by CDC Clinical Disease Classification. Presented at the Pediatric Academic Societies Meeting, April 2001. 
  14. Gilles J, Creinin M, Westhoff C, Barnhart K, Frederick M, Zhang J.  Wet Versus Dry Intravaginal Misoprostol Application for Treatment of Early Pregnancy Failure.  Presented at the 58th Annual Meeting of the American Society of Reproductive Medicine (ASRM), Seattle, Washington, October 12-17, 2002.
  15. Barnhart KT, Zhang J, Giles J, Westoff C, Creinin M, Frederick M.  Hormonal Predictors of Successful Medical Management of a Nonviable First-Trimester Gestation with Misoprostol.  (Abstract).  The American College of Obstetricians and Gynecologists, 51st Annual Clinical Meeting, New Orleans, LA.  April 2003.  Obstetrics and Gynecology.  2003; 101:51S.
  16. Crenin MD, Zhang J, Gilles J, Barnhart K, Westhoff C, Frederick M.  Medical management with misoprotstol for early pregnancy failure.  (Abstract).  The Association of Reproductive Health professionals (ARHP) Annual Meeting.  Washington, D.C.  September 8-10, 2004.  Contraception.  2004; 70:255.
  17. Zhang J, Gilles J, Barnhart K, Creinin M, Westhoff C, Frederick M for the NICHD Management of Early Pregnancy Failure Trial Group.  Medical management with Misoprostol for Early Pregnancy Failure: A Multicenter, Randomized Equivalence Trial.  Presented at the 60th Annual Meeting of the American Society for Reproductive Medicine, Philadelphia, PA.  October 2004. 
  18. Shepherd JA, Fan B, Sherman M, Gilsanz V, Horlick M, Kalkwarf H, Lappe J, Mahboubi S, Zemel B, Frederick M, Winer K. Pediatric DXA Precision Varies with Age.  26th Annual Meeting of the American Society for Bone and Mineral Research, Seattle, WA.  2004. 
  19. Horlick M, Lappe JM, Gilsanz V, Kalkwarf HJ, Zemel BS, mahboubi S, Shepherd JA, Frederick MM, Winer K.  The Bone Mineral Density in Childhood Study (BMDCS): Baseline Results for 1554 Healthy Pediatric Volunteers.  26th Annual Meeting of the American Society for Bone and Mineral Research, Seattle, WA., 2004. 
  20. Wren TAL, Gilsanz V, Pitukcheewanont P, Liu X, Horlick M. Lappe JM, Kalkwarf H, Zemel BS, Mahboubi S, Shepherd JA, Frederick MM, Winer K.  The Bone Mineral Density in Childhood Study (BMDCS): Substudy Comapring DXA and CT Vertebral Bone Measurements in Healthy Children and Adolescents.  26th Annual Meeting of the American Society for Bone and Mineral Research, Seattle, WA., 2004. 
  21. Lappe J, Lypaczewski G, Huang X, Horlick M, Gilsanz V, kalkwarf H, Zemel B, Mahboubi S, Shepherd J, Frederick M, Winer K.  Defining the healthy americaqn child: Characteristics of children in the Bone Mineral Density in Childhood Study.  Poster presentation at the 3rd International Conference on Child Bone Health, May 2005, Naples, Italy.  Abstract published in Bone, 36, Suppl, pS75. 
  22. Zemel B, Kalkwarf H, Leonard M, Shepherd J, Mahboubi S, Frederick M, Winer K. Effects of skeletal and sexual maturation on trabecular and cortical density of the peripheral skeleton.  27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, TN, 2005.  Abstract published in J Bone Mineral Res 2005; 20(Suppl1):59. 
  23. Kalkwarf H, Zemel B, Lappe J, Shepherd J, Oberfield S, Huang X, Frederick M, Winer K, Gilsanz V.  Tracking of bone mass and density during growth and maturation.  28th      Annual Meeting of the American Society for Bone and Mineral Research, Philadelphia, PA, 2006.  Abstract published in J Bone Mineral Res.  2006; 21 (Suppl 1);S124.
  24. Shepherd JA, Lu Y, Zhao S, Gilsanz V, Kalkwarf H, Lappe J, Oberfield S, Zemel B, Fan B, Wren T, Frederick M, Winer K.  Fracture risk is associated with race, height, and bone mineral density in healthy children.  28th Annual Meeting of the American Society for Bone and Mineral Research, Philadelphia, PA,  2006. 
  25. Zemel B, Mahboubi S, Kalkwarf H, Gilsanz V, Shepherd J, Oberfield S, Lappe J, Frederick M, Winer K.  28th Annual Meeting of the American Society for Bone and Mineral Research, Philadelphia, PA, 2006.  Abstract published in J Bone Mineral Res. 2006:21(suppl 1): S21. 
  26. Lappe J, Gilsanz V, Kalkwarf H, Mahboubi S, Oberfield S, Shepherd J, Zemel B, Frederick M, Winer K, Haynatzki G.  Physical activity and bone density in a large cohort of U.S. children.  28th Annual Meeting of the American Society for Bone and Mineral Research, Philadelphia, PA.  2006.  Abstract published in J Bone Mineral Res. 2006:21(suppl 1). 
  27. Zemel B, Kalkwarf H, Mahboubi S, Gilsanz V, ;Lappe J, Oberfield S, Shepherd J, Frederick M, Winer K. Effect of Bone Age on Bone Density Z-Scores in Childhood. Results from the Bone Mineral Density in Childhood Study. International Conference on Children’s Bone Health, Montreal, June 2007.
  28. Bartholmai BJ, Han MK, Curtis JL, Robb RA, Karwoski RA, Sciurba FC, Frederick MM, Thompson BW.  Correlation of visual and quantitative CT measures of disease with physiologic parameters in the Lung Tissue Research Consortium (LTRC) Database of COPD Subjects.  Presented at the 2008 ATS Annual Meeting.  AJRCCM, 177:A661.
  29. Bartholmai BJ, Martinez FJ, Han MK, Curtis JL, Robb RA, Karwoski RA, Sciurba FC, Frederick MM, Li D, Thompson BW.  Correlation of radiologist visual assessment of COPD features with quantitative measures of disease on volumetric high-resolution CGT of the chest.  A Lung Tissue Research Consortium (LTRC) Study. Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A755.
  30. Freeman CM, Martinez FJ, Arenberg DA, Chensue SW, Murphy HS, Meldrum C, Han MS, Flaherty DK, Frederick M, Thompson B, Curtis JL.  Lung IL-15 Production in COPD correlates with measures of disease severity: A study using LTRC resources. Presented at the 2008 ATS Annual Meeting.  AJRCCM, 177:A961.
  31. Han MK, Bartholmai B, Flaherty KR, Limper A, Frederick M, Thompson B, Li D, Thannickal V, Toews GB, Martinez FJ.  Gender differences in SGRQ in patients with IPF.Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A251.
  32. Han MK, Bartholmai B, Curtis JL, Limper A, Sciurba FC, Bon JM, Robb RA, Karwoski RA, Frederick M, Thompson B, Li D, Flaherty KR, Schwarz MI, Martinez FJ.  Emphysema percent predicts quality of life and symptoms in COPD: An analysis of Lung Tissue Research Consortium patients. Presented  at the 2008 ATS Annual Meeting.  AJRCCM, 177:A520.

Li, Daner

  1. Li D, Thompson B. Abstract >Height and weight reference growth curves for children with sickle cell anemia=. Accepted for The 3rd joint meeting of the International Society for Clinical Biostatistics (ISCB) and Society for Clinical Trials (SCT) in London, July 20th-24th, 2003.
  2. Wang W, Rees R, Li D, et al.  Evaluation of renal function by glomerular filtration rate (GFR) in infants with sickle cell anemia.  46th Annual Meeting, ASH, San Diego CA, December 2004 (poster).  Blood 2004; 104:465a.
  3. Rogers ZR, Rees RR, Et al.  Evaluation of splenic function in infants with sickle cell anemia in the BABY HUG Trial.  46th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati OH, April 2005.  Blood 2004; 104:975a.
  4. Armstrong FD, Rees R, Li D, et al.  Baseline developmental function by age for children in the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug).  28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati OH, April 2005.
  5. Adams RJ, Luden J, et al.  TCD in infants treated with hydroxyurea: interim report from BABY HUG study.  28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati OH, April 2005.
  6. Casella JF, Wang WC, et al.  Progress of the multicenter trial of hydroxyurea in infants with sickle cell anemia (BABY HUG) and assessment of baseline splenic and renal function.  ASPHO/PAS, Washington DC, May 2005.  Pediatric Blood Cancer 2005; 44:551.
  7. Adams RJ, Barredo J, et al.  TCD in infants: a report for the BABY HUG trial.  Blood 2005; 106:280a.
  8. Miller S, Barredo J, et al.  Renal concentrating ability in infants with sickle cell anemia; preliminary data from BABY HUG, a multicenter trial.  Renal and Urology Complications in Sickle Cell Disease Workshop, Annual Sickle Cell Disease Clinical Research Meetings, National Institutes of Health Campus, Bethesda Maryland, August 29, 2005.
  9. Ware RE, Miller ST, et al.  Assessment of renal function in the Phase III Multicenter Hydroxyurea (BABY HUG) Trial for Infants with Sickle Cell Anemia.  Renal and Urology Complications in Sickle Cell Disease Workshop, Annual Sickle Cell Disease Clinical Research Meetings, Nation Institutes of Health Campus, Bethesda Maryland, August 29, 2005.
  10. Wang W, Helton KJ, et al.  MRI abnormalities are present in one year-old children with sickle cell anemia.  29th Annual Meeting of the National Sickle Cell Disease Program, Memphis TN, April 2006.
  11. Miller S, Barredo J, et al.  Renal concentrating ability in infants with sickle cell anemia; baseline data from BABY HUG, a multicenter trial.  29th Annual Meeting of the National Sickle Cell Disease Program, Memphis TN, April 2006.

Lu, Ming

  1. Circadian Regulation of IL-6, IL-1β and IL-1RA Levels is Disrupted in HIV-Infected Children, S. B. Foster, M. Lu, J. Reuben, E. Cohen, D. Asthana, B. Thompson, W. T. Shearer (FOCIS 2009)
  2. HLA inheritance and asthma in HIV-infected children, S. B. Foster, M. Lu, B. Thompson, K. S. MacDonald, R. J. Winchester, K. C. Rich, W. T. Shearer (FOCIS 2008)
  3. Increased incidence of asthma in HIV-infected children on HAART in the NIH Women and Infants Transmission Study, SB Foster, K McIntosh, B Thompson, W Yin, M Lu, KC Rich, H Mendez, LK Serchuck, C Diaz, WT Shearer (ATS 2008)
  4. Treatment Interruption after Pregnancy and Disease Progression:  A Report from the Women and Infants Transmission Study, DH Watts, LM Mofenson, M Lu, B Thompson. The 14th Conference on Retroviruses and Opportunistic Infections (CROI 2007)
  5. Perinatal Antiretroviral(ARV) Exposure and Effect on Hematopoiesis in HIV-Exposed, Uninfected Children: The Women and Infants Transmission Study, L. Mofenson, M. Lu, Spacheco, E. Handelsman, K. etc. XV International AIDS Conference, Abstract ThPeB7024 7/15/2004.
  6. Dewar, D., Lu, M., Dickson, K. Gender differences in critical care resource utilization and health outcomes among the elderly. Presented at session sponsored by the Gerontological Section, Annual Meeting of the American Public Health Association, Atlanta, GA, 2001.
  7. Dewar, D., Lambrinos, J., Lu, M. Impacts of managed care and competitive reimbursements on hospital resource utilization for the critically ill. Presented at session sponsored by the Health Economics Committee of the Medical Care Section, Annual Meeting of the American Public Health Association, Atlanta, GA, 2001.

Luo, Zhaoyu

  1. Luo Z, J.Cabrera, X.Yu and P.Wong. Sample Size for Identifying Differentially Expressed Genes in Microarray Experiment.   2008 Joint.Statistical meetings. 
  2. Luo Z and Cabrera J.  When Means and Variance Are Related, Improved Conditional T Test for Identifying Differentially Expressed Genes.  2007 ASHG Annual Meeting.  
  3. Luo Z, Cabrera J and X.Yu.  Powering it up: Analysis of Microarray Data Using Estimated Correlation Matrix   2007 ICSA Symposium.

Thompson, Bruce

  1. Thompson BW.  Dose-response models for chemical carcinogens -- An interaction between statistics and biology.  Invited presenta­tion at the Environmental Protection Agency, February, 1982.
  2. Thompson BW.  Invited consultation for the protocol development of trial IV, European Organization for Research on Treatment of Cancer November, 1984.
  3. Thompson BW.  A semiparametric test to detect initial hazard free intervals.  Presented at the Biometrics - ENAR meetings, March, 1986, Atlanta, Georgia.
  4. Thompson BW.  Considerations for the analysis of large clinical trials with survival as an outcome.  Department of Epidemiology & Preventive Medicine, July, 1986.
  5. Thompson BW.  The use of time dependent variables in controlled clinical trials.  (Invited Presentation) University of Missouri, April 1988.
  6. Thompson B, Handy C and Terrin M.  Imputing missing values under order restrictions.  Society for Controlled Clinical Trials, May 1988.
  7. Thompson B, Knatterud GL.  The use of factorial designs when the outcome variable is binary: What happens when low level interactions are present.  Society for Clinical Trials, May 1989.
  8. Thompson B, Barton F.  Visualizing the effect of time-dependent covariates using the Cox Model: A simple method and application.  Society for Clinical Trials, May 1991.
  9. Thompson B.  Analysis of composite end points when some components are missing.  (Invited Presentation).  Biometrics Meetings ENAR, April, 1994. 
  10. Knatterud G, Thompson B, Fox N, Barton B.  Clinical Trials in Behavioral Medicine (Part 2).  Advanced concepts and special considerations in behavioral clinical trials (Workshop).  Third International Congress of Behavioral Medicine. 
  11. Thompson BW. Innovative designs in behavioral trials.  9th International Symposium on Long-Term Clinical Trials.  London, England.  June 19-20, 2000 (In Press). 
  12. Rogers ZR, Rees RC, Wang WC, Li D, Iyer RV, Rana S, Barredo JC, Casella JF, Driscoll MC, Toledano S, Miller ST, Zimmerman SA, Miller JH, Shalaby-Rana E, Dertinger S, Thompson B, Ware RE.  Evaluation of splenic function in infants with sickle cell anemia in the BABY HUG trial.  Poster presented at the American Society of Hematology Meeting, December 2004.  Abstract published in meeting proceedings.
  13. Wang W, Rees R, Li D, Rogers Z, Iyer R, Rana S, Baredo J, Casella J, Driscoll C, Toledano S, Miller S, Zimmerman S, Shalaby-Rana E, Miller J, Thompson B, Ware R for the BABY HUG Investigators.  Evaluation of renal function by glomerular filtration rate (GFR) in infants with sickle cell anemia.  Poster presented at the American Society of Hematology Meeting, December 2004.  Abstract published in meeting proceedings. 
  14. Lipshultz SE, Shearer, WT, Rich K, Thompson B, Cheng I, Harmon T, Orav EJ, Pignatelli RH, Bezold LI, La Russa P, Starc TJ, Glickstein J, O’Brien S, McIntosh K, Cooper ER, Colan SD. Antiretroviral therapy (ART)-associated cardiotoxicity in uninfected but ART-exposed infants born to HIV-infected women: The prospective NHLBI CHAART-1 Study. Ninth International Conference on Environmental Mutagens, 2005. Abstract published in meeting proceedings.
  15. Ware RE, Miller ST, Rees R, Iyer RV, Rogers ZR, Zimmerman SA, Minitti C, Barredo J, Rana S, Casella J, Toledano S, Li D, Thompson B, Wang WC. Assessment of renal function in the Phase III Multicenter Hydroxyurea (BABY HUG) Trial for infants with sickle cell anemia. Renal and Urology Complications in Sickle Cell Disease Workshop, Annual Sickle cell Disease Clinical Research Meetings, National Institutes of Health Campus, Bethesda, Maryland, August 2005.  Abstract published in meeting proceedings.
  16. Casella JF, Wang WC, Rogers ZR, Rees R, Iyer RV, Rana S, Driscoll MC, Miller ST, Toledano S, Barredo J, Zimmerman SA, Li D, Ware RE, Thompson B. Progress of the multicenter trial of hydroxyurea in infants with sickle cell anemia (BABY HUG) and assessment of baseline splenic and renal function.  ASPHO/PAS Meeting, Washington, D.C., May 2005. Pediatric Blood Cancer 2005;44:551.
  17. Thompson BW, Renee Rees, PhD.  The impact of systemic treatment interruptions during a clinical trial.  Society for Clinical Trials Annual Meeting, Montreal, Canada, May 20-23, 2007.  Abstract published in meeting proceedings. 
  18. Thompson BW, Chu C, Richards T.  Sample size estimation for factorial designs in microarray studies.  Contributed Paper.  2007 Joint Statistical Meetings, Salt Lake City, Utah. 
  19. Bartholmai BJ, Han MK, Curtis JL, Robb RA, Karwoski RA, Sciurba FC, Frederick MM, Thompson BW.  Correlation of visual and quantitative CT measures of disease with physiologic parameters in the Lung Tissue Research Consortium (LTRC) Database of COPD Subjects, Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A661.
  20. Bartholmai BJ, Martinez FJ, Han MK, Curtis JL, Robb RA, Karwoski RA, Sciurba FC, Frederick MM, Li D, Thompson BW.  Correlation of radiologist visual assessment of COPD features with quantitative measures of disease on volumetric high-resolution CGT of the chest.  A Lung Tissue Research Consortium (LTRC) Study.  Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A755.
  21. Freeman CM, Martinez FJ, Arenberg DA, Chensue SW, Murphy HS, Meldrum C, Han MS, Flaherty DK, Frederick M, Thompson B, Curtis JL.  Lung IL-15 Production in COPD correlates with measures of disease severity: A study using LTRC resources.  Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A961.
  22. Han MK, Bartholmai B, Flaherty KR, Limper A, Frederick M, Thompson B, Li D, Thannickal V, Toews GB, Martinez FJ.  Gender differences in SGRQ in patients with IPF. Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A251.
  23. Han MK, Bartholmai B, Curtis JL, Limper A, Sciurba FC, Bon JM, Robb RA, Karwoski RA, Frederick M, Thompson B, Li D, Flaherty KR, Schwarz MI, Martinez FJ.  Emphysema percent predicts quality of life and symptoms in COPD: An analysis of Lung Tissue Research Consortium patients. Presented at the 2008 ATS Annual Meeting. AJRCCM, 177:A520.
  24. Han MK, Bartholmai B, Flaherty KR, Limper A, Schwarz MI, Thannickal VJ, Frederick M, Thompson B, Li D, Toews GB, Martinez FJ.  Gender differences in emotional function in patients with IPF: A Lung Tissue Research Consortium Study.  Presented at the 2008 ATS Annual Meeting.  AJRCCM, 177:A886.

Wang, Yuxia

  1. Wang Y., (Oct. 12, 2007), The Effect of Education on Glycosylated Hemoglobin (A1c) Values of Diabetes Patients, the 4th Research Day of the College of Public Health Conference, Lexington, KY.

Professional Poster:

  1. Wang Y., (Oct. 12, 2007), SAS and Longitudinal Data, the 4th Research Day of the College of Public Health Conference, Lexington, KY.
COMPANY
History
Clients & Partners
Management
Publications

Recent News

C-TASC Exhibits at DIA Conference.

San Diego, CA - November 14, 2011 - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, exhibited at the 10th DIA ...

C-TASC Published in American Heart Association Journal.

Baltimore, MD - October 24, 2011 - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, recently co-authored (Sandra ...

C-TASC Hires Ph.D. Senior Statistician.

Baltimore, MD - June 6, 2011 - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today it has hired Margaret A. Connolly, Ph.D. ...